UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549...
FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...
Common stock to commence trading on the Nasdaq Capital Market on July 1, 2021 under the ticker symbol “PNT”...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC...
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL...
TABLE OF CONTENTS Filed Pursuant to Rule 424(b)(3) Registration No...
Special Meeting Scheduled for June 29, 2021 Therapeutics Acquisition Corp, d/b/a Research Alliance Corp. I, a Delaware corporation (“the...
TABLE OF CONTENTS As filed with the Securities and Exchange Commission on June 4, 2021 No...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ...
POINT Biopharma Inc. (POINT), a global radiopharmaceutical company dedicated to successfully delivering precision radioligand therapy to cancer...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.